NCT03307122View on ClinicalTrials.gov

Gastrointestinal Tolerance Evaluation of an Infant Formula

NACompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

September 21, 2017

Primary Completion Date

January 19, 2018

Study Completion Date

January 19, 2018

Conditions
Healthy, Full-term Infants Who Are Formula-fed
Interventions
OTHER

Routine Infant Formula 1

Routine infant formula with probiotic

OTHER

Routine Infant Formula 2

Routine infant formula with probiotic and prebiotic

Trial Locations (8)

29414

Coastal Pediatric Associates, Charleston

32503

Avanza Medical Research Center, Pensacola

38116

Midsouth Center for Clinical Research, LLC, Memphis

40291

Bluegrass Clinical Research, Inc., Louisville

42310

PediaResearch, Owensboro

45414

Ohio Pediatric Research Association, Dayton

78229

Southwest Children's Research Associates, San Antonio

84041

Tanner Clinic, Layton

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY

NCT03307122 - Gastrointestinal Tolerance Evaluation of an Infant Formula | Biotech Hunter | Biotech Hunter